에스티팜
Not investment advice · For research purposes only; not a solicitation or an offer of any financial product. Past statistics do not indicate future outcomes. Facts from filings and public sources; not investment advice. No valuation estimate, direction or trading levels are provided.
① Fact table
Values as filed · consolidated / separate basis per year · no interpretation
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | Unit |
|---|---|---|---|---|---|---|
| 매출액 | 165,641,947,051 | 249,321,677,973 | 284,991,652,409 | 273,751,342,840 | 331,681,282,447 | KRW |
| 영업이익 | 5,577,586,579 | 17,851,415,161 | 33,511,661,589 | 27,692,533,192 | 54,932,543,750 | KRW |
| 당기순이익 | 3,312,124,537 | 18,000,015,281 | 19,581,189,748 | 34,711,730,618 | 54,991,748,144 | KRW |
| 자본총계 | 322,974,127,532 | 337,631,831,326 | 384,550,358,519 | 503,132,372,466 | 593,442,577,191 | KRW |
| 부채총계 | 172,532,637,472 | 229,549,274,594 | 288,529,670,073 | 218,884,522,840 | 189,563,266,216 | KRW |
| 부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준)· in house | 53.42 | 67.99 | 75.03 | 43.50 | 31.94 | % |
| Statement basis | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated |
Source: dart_fnltt · Computed in house · card as of 2026-10-13 · Filing date per year: not on the card (see the filing timeline below) · 'in house' marks items computed from the values above
② Profitability breakdown
Arithmetic on the fact table only · same year, same basis · '—' where a value is missing or the denominator is 0 or below · in each panel the bar height maps the span from the most negative to the largest positive value onto the panel height · no interpretation attached
Source: computed in house from the fact table · card as of 2026-10-13
③ My own calculation
A simple residual-income formula. You enter the assumptions; only the base equity is filled in from the filing. The result is computed from your assumptions and is not a figure this site publishes.
V = B₀ + (ROE − r) × B₀ ÷ (1 + r − ω)
Fill in all four boxes to compute. The site fills in nothing but the base equity.
Computed in this browser only; nothing you type is sent or stored.
- Base close 2026-10-13
- 86,000
- 80%
- 81,436.46 ~ 91,043.84
- 90%
- 80,034.21 ~ 93,721.96
- Ledger row
- f8cdff4b…
Source: fsc_stock_price · published 2026-10-14T11:05:08+09:00 · No direction implied
No day scored yet — no basis for a hit rate.
- 2026-10-08Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
- 2026-10-06Filing title as filed투자판단관련주요경영사항(임상시험결과) (HIV-1 치료제 STP0404 임상 2a상 임상시험결과보고서(CSR) 수령) original ↗Source: dart_disclosure
- 2026-10-02Filing title as filed주식등의대량보유상황보고서(약식) original ↗Source: dart_disclosure
- 2026-09-18Filing title as filed단일판매ㆍ공급계약체결 original ↗Source: dart_disclosure
- 2026-09-09Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-08-14Filing title as filed반기보고서 (2026.06) original ↗Source: dart_disclosure
- 2026-08-11Filing title as filed전환사채(해외전환사채포함)발행후만기전사채취득 original ↗Source: dart_disclosure
- 2026-07-31Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-07-27Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-07-27Filing title as filed연결재무제표기준영업(잠정)실적(공정공시) original ↗Source: dart_disclosure
- 2026-07-23Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-07-23Filing title as filed결산실적공시예고 original ↗Source: dart_disclosure
- 2026-07-14Filing title as filed투자판단관련주요경영사항(임상시험결과) (HIV-1 치료제 STP0404 임상 2a상 임상시험 탑라인 결과) original ↗Source: dart_disclosure
- 2026-06-22Filing title as filed지속가능경영보고서등관련사항(자율공시) original ↗Source: dart_disclosure
- 2026-06-02Filing title as filed[기재정정]사업보고서 (2025.12) original ↗Source: dart_disclosure
- 2026-05-15Filing title as filed분기보고서 (2026.03) original ↗Source: dart_disclosure
- 2026-05-14Filing title as filed기업설명회(IR)개최 original ↗Source: dart_disclosure
- 2026-04-30Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-04-30Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗Source: dart_disclosure
- 2026-04-30Filing title as filed주식등의대량보유상황보고서(일반) original ↗Source: dart_disclosure
| Layer | Badge | n | Note |
|---|---|---|---|
| range | unknown | 0 | 80%·90% 범위의 전향 적중 기록(목표일 개장 전 박제 → 종가 공표 뒤 채점) |
| fair_value | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| direction | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| trade_levels | 제공 안 함 | 0 | 판별력 미확인 — 싣지 않음 |
| Valuation estimate | not provided | — | Not published: no demonstrated discriminative power |
| Direction (up or down) | not provided | — | Not published: no demonstrated discriminative power |
| Trading levels | not provided | — | Not published: no demonstrated discriminative power |
Why this?
Checking…